# Breye Therapeutics funding rounds and investors

As of 22 Nov 2026, Breye Therapeutics has raised $75.8M across 1 verified round on record (amounts in other currencies converted to USD), plus 1 round still being checked; latest: €67.5 million Series A led by Mission BioCapital and Novo Holdings, announced 29 Sep 2026.

A clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases

Website: https://breye.com  
Headquarters: Copenhagen, Denmark  
Page: https://fireround.dev/companies/breye-therapeutics-aps

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-09-29 | Series A | €67.5 million | Mission BioCapital, Novo Holdings | Catalyze Capital, EIFO, Innovestor Life Science Fund, Ljungström family office, Modi Ventures, Pappas Capital, Sound Bioventures | [breye.com](https://breye.com/breye-therapeutics-raises-e67-5-million-in-over-subscribed-series-a-financing), [globenewswire.com](https://www.globenewswire.com/news-release/2026/09/29/3370426/0/en/breye-therapeutics-raises-67-5-million-in-over-subscribed-series-a-financing.html), [markets.businessinsider.com](https://markets.businessinsider.com/news/stocks/breye-therapeutics-raises-67-5-million-in-over-subscribed-series-a-financing-1036580379) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.
